Rheumatoid Arthritis Clinical Trials

Showing 561-580 of 40,629 trials

Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

NCT07530705

XH-02 is an mRNA nucleic acid drug that expresses PTH in the body following intravenous or subcutaneous injection, providing PTH replacement therapy for patients with hypoparathyroidism. Animal studies have shown pharmacodynamic effects of XH-02, with a favorable safety profile. A clinical study of intravenously administered XH-02 has been completed in patients with hypoparathyroidism, yielding clear pharmacodynamic results and demonstrating good safety. This study aims to evaluate the safety and efficacy of subcutaneously injected XH-02 in patients with hypoparathyroidism.

Hypoparathyroidism

Peking Union Medical College Hospital15 participantsStarted Nov 2025

Beijing, Beijing Municipality, China

Not Yet RecruitingNA

Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study

NCT07522138

This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.

Home Exercise ProgramPD - Parkinson's DiseaseFeasibility Studies

Seoul National University Hospital15 participantsStarted Apr 2026

Seongnam-si, South Korea

Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study

Related Searches

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene

Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

LED Treatment to Improve Cognition and Promote Recovery in TBI

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling

The Selective Intraperineural Nerve Root Block Study

Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder

Membrane Stripping for Cervical Ripening

n-3 PUFAs, Irisin and Maternal Glucose Metabolism From Pregnancy to Postpartum

A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NSS Grocery Store Brazil

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)

APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas